-
公开(公告)号:US20050043301A1
公开(公告)日:2005-02-24
申请号:US10923067
申请日:2004-08-20
申请人: Longbin Liu , Patricia Lopez , Manoj Bajpai , Aaron Siegmund
发明人: Longbin Liu , Patricia Lopez , Manoj Bajpai , Aaron Siegmund
IPC分类号: C07D401/04 , C07D487/04 , C07D417/02 , A61K31/513 , A61K31/5377 , A61K31/541 , C07D43/02
CPC分类号: C07D487/04 , C07D401/04
摘要: The present invention relates to compounds having the general formula or a pharmaceutically acceptable salt thereof, wherein R1 is a saturated or unsaturated 5-, 6- or 7-membered, ring containing 0, 1, 2 or 3 atoms selected from N, O and S, wherein the ring may be fused with a benzo group, and is substituted by 0, 1 or 2 oxo groups, and wherein R1 is additionally substituted; and R2 is a substituted C1-6alkyl. Also included is a method of prophylaxis or treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic β cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.
-
公开(公告)号:US20060069110A1
公开(公告)日:2006-03-30
申请号:US11237513
申请日:2005-09-27
申请人: Denise Andersen , Catherine Chang , James Falsey , Michael Frohn , Fang-Tsao Hong , Hongyu Liao , Longbin Liu , Patricia Lopez , Daniel Retz , Gilbert Rishton , Robert Rzasa , Aaron Siegmund , Seifu Tadesse , Nuria Tamayo , Christopher Tegley
发明人: Denise Andersen , Catherine Chang , James Falsey , Michael Frohn , Fang-Tsao Hong , Hongyu Liao , Longbin Liu , Patricia Lopez , Daniel Retz , Gilbert Rishton , Robert Rzasa , Aaron Siegmund , Seifu Tadesse , Nuria Tamayo , Christopher Tegley
IPC分类号: A61K31/506 , C07D403/14 , C07D403/04
CPC分类号: C07D239/48 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14
摘要: The present invention relates to pyridines, pyrimidines and derivatives thereof, and pharmaceutically acceptable salts thereof. Also included is a method of treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic β cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.
摘要翻译: 本发明涉及吡啶,嘧啶及其衍生物及其药学上可接受的盐。 还包括治疗炎症,类风湿性关节炎,斑节病,骨质疏松症,多发性骨髓瘤,葡萄膜炎,急性或慢性骨髓性白血病,胰腺β细胞破坏,骨关节炎,类风湿性脊椎炎,痛风性关节炎,炎性肠病,成人呼吸窘迫综合征 (ARDS),牛皮癣,克罗恩病,过敏性鼻炎,溃疡性结肠炎,过敏反应,接触性皮炎,哮喘,肌肉变性,恶病质,赖特综合征,I型糖尿病,II型糖尿病,骨吸收疾病,移植物抗宿主反应,阿尔茨海默病 ,中风,心肌梗塞,缺血再灌注损伤,动脉粥样硬化,脑外伤,多发性硬化,脑疟疾,败血症,败血性休克,中毒性休克综合征,发热,HIV-1,HIV-2,HIV-3,巨细胞病毒 ),流感病毒,腺病毒,哺乳动物中的疱疹病毒或带状疱疹感染,包括给予有效量的如上所述的化合物。
-
公开(公告)号:US07504403B2
公开(公告)日:2009-03-17
申请号:US11041151
申请日:2005-01-21
申请人: Michael J. Frohn , Fang-Tsao Hong , Longbin Liu , Patricia Lopez , Aaron Siegmund , Seifu Tadesse , Nuria Tamayo
发明人: Michael J. Frohn , Fang-Tsao Hong , Longbin Liu , Patricia Lopez , Aaron Siegmund , Seifu Tadesse , Nuria Tamayo
IPC分类号: C07D487/04 , A61K31/506
CPC分类号: C07D487/04 , C07D471/04
摘要: The present invention relates to pyrimidinones and pyridones and derivatives thereof, and pharmaceutically acceptable salts thereof. Also included is a method of treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic β cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.
摘要翻译: 本发明涉及嘧啶酮和吡啶酮及其衍生物及其药学上可接受的盐。 还包括治疗炎症,类风湿性关节炎,斑节病,骨质疏松症,多发性骨髓瘤,葡萄膜炎,急性或慢性骨髓性白血病,胰腺β细胞破坏,骨关节炎,类风湿性脊椎炎,痛风性关节炎,炎性肠病,成人呼吸窘迫综合征 (ARDS),牛皮癣,克罗恩病,过敏性鼻炎,溃疡性结肠炎,过敏反应,接触性皮炎,哮喘,肌肉变性,恶病质,赖特综合征,I型糖尿病,II型糖尿病,骨吸收疾病,移植物抗宿主反应,阿尔茨海默病 ,中风,心肌梗塞,缺血再灌注损伤,动脉粥样硬化,脑外伤,多发性硬化,脑疟疾,败血症,败血性休克,中毒性休克综合征,发热,HIV-1,HIV-2,HIV-3,巨细胞病毒 ),流感病毒,腺病毒,哺乳动物中的疱疹病毒或带状疱疹感染,包括给予有效量的如上所述的化合物。
-
公开(公告)号:US20050187223A1
公开(公告)日:2005-08-25
申请号:US11041151
申请日:2005-01-21
申请人: Michael Frohn , Fang-Tsao Hong , Longbin Liu , Patricia Lopez , Aaron Siegmund , Seifu Tadesse , Nuria Tamayo
发明人: Michael Frohn , Fang-Tsao Hong , Longbin Liu , Patricia Lopez , Aaron Siegmund , Seifu Tadesse , Nuria Tamayo
IPC分类号: A61K31/506 , A61K31/513 , A61K31/519 , C07D471/04 , C07D487/04
CPC分类号: C07D487/04 , C07D471/04
摘要: The present invention relates to pyrimidinones and pyridones and derivatives thereof, and pharmaceutically acceptable salts thereof. Also included is a method of treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic β cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.
摘要翻译: 本发明涉及嘧啶酮和吡啶酮及其衍生物及其药学上可接受的盐。 还包括治疗炎症,类风湿性关节炎,斑节病,骨质疏松症,多发性骨髓瘤,葡萄膜炎,急性或慢性骨髓性白血病,胰腺β细胞破坏,骨关节炎,类风湿性脊椎炎,痛风性关节炎,炎性肠病,成人呼吸窘迫综合征 (ARDS),牛皮癣,克罗恩病,过敏性鼻炎,溃疡性结肠炎,过敏反应,接触性皮炎,哮喘,肌肉变性,恶病质,赖特综合征,I型糖尿病,II型糖尿病,骨吸收疾病,移植物抗宿主反应,阿尔茨海默病 ,中风,心肌梗塞,缺血再灌注损伤,动脉粥样硬化,脑外伤,多发性硬化,脑疟疾,败血症,败血性休克,中毒性休克综合征,发热,HIV-1,HIV-2,HIV-3,巨细胞病毒 ),流感病毒,腺病毒,哺乳动物中的疱疹病毒或带状疱疹感染,包括给予有效量的如上所述的化合物。
-
公开(公告)号:US06849639B2
公开(公告)日:2005-02-01
申请号:US09732546
申请日:2000-12-08
申请人: Celia Dominguez , Guoqing Chen , Ning Xi , Shimin Xu , Nianhe Han , Qingyian Liu , Qi Huang , Aaron Siegmund , Michael Handley , Longbin Liu , Alexander Kiselyov
发明人: Celia Dominguez , Guoqing Chen , Ning Xi , Shimin Xu , Nianhe Han , Qingyian Liu , Qi Huang , Aaron Siegmund , Michael Handley , Longbin Liu , Alexander Kiselyov
IPC分类号: C07D401/06 , A61K31/402 , A61K31/4025 , A61K31/4178 , A61K31/4355 , A61K31/438 , A61K31/4406 , A61K31/4709 , A61K31/496 , A61K31/506 , A61P3/10 , A61P9/00 , A61P9/10 , A61P17/02 , A61P19/00 , A61P27/02 , A61P29/00 , A61P35/00 , A61P35/04 , C07D207/26 , C07D207/277 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/14 , C07D417/14 , C07D471/10
CPC分类号: C07D207/277 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D417/14
摘要: The invention comprises novel compounds that are effective in the prophylaxis and treatment of diseases, such as integrin receptors mediated diseases, in particular, diseases or conditions mediated by integrin receptors, such as a αvβ3, αvβ5, αvβ6, α5β1 and the like. The invention encompasses novel compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of such diseases and disorders. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
摘要翻译: 本发明包括有效预防和治疗诸如整联蛋白受体介导的疾病,特别是整联蛋白受体介导的疾病或病症的新型化合物,例如阿尔法派3,阿尔法派5,阿尔法博特6,α5β1等。 本发明包括新型化合物,其药学上可接受的盐,用于预防和治疗这些疾病和病症的药物组合物和方法。 本发明还涉及制备这些化合物的方法以及在这些方法中有用的中间体。
-
公开(公告)号:US07049318B2
公开(公告)日:2006-05-23
申请号:US10897884
申请日:2004-07-23
IPC分类号: A61K31/505
CPC分类号: C07D401/14 , C07D401/04 , C07D487/04
摘要: The present invention relates to compounds having the general formula or a pharmaceutically acceptable salt thereof, wherein R1 is a saturated or unsaturated 5-, 6- or 7-membered, ring containing 0, 1, 2 or 3 atoms selected from N, O and S, wherein the ring may be fused with a benzo group, and is substituted by 0, 1 or 2 oxo groups, and wherein R1 is additionally substituted; and R2 is a substituted C1-6alkyl. Also included is a method of prophylaxis or treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic β cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.
-
公开(公告)号:US20060252777A1
公开(公告)日:2006-11-09
申请号:US11289659
申请日:2005-11-29
申请人: Tae-Seong Kim , Steven Bellon , Shon Booker , Noel D'Angelo , Celia Dominguez , Ingrid Fellows , Matthew Lee , Longbin Liu , Elizabeth Rainbeau , Aaron Siegmund , Andrew Tasker , Ning Xi , Yuan Cheng
发明人: Tae-Seong Kim , Steven Bellon , Shon Booker , Noel D'Angelo , Celia Dominguez , Ingrid Fellows , Matthew Lee , Longbin Liu , Elizabeth Rainbeau , Aaron Siegmund , Andrew Tasker , Ning Xi , Yuan Cheng
IPC分类号: A61K31/519 , A61K31/517 , A61K31/513 , A61K31/4709 , A61K31/4745 , C07D403/04 , C07D487/02 , C07D471/02
CPC分类号: C07D401/14 , C07D215/233 , C07D401/12 , C07D409/14 , C07D413/12
摘要: Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
摘要翻译: 所选化合物对于预防和治疗诸如HGF介导的疾病等疾病是有效的。 本发明包括新颖的化合物,类似物,前药和药学上可接受的盐,用于预防和治疗疾病和其它疾病或涉及癌症等的病症的药物组合物和方法。 本发明还涉及制备这些化合物的方法以及在这些方法中有用的中间体。
-
公开(公告)号:US20050020592A1
公开(公告)日:2005-01-27
申请号:US10897884
申请日:2004-07-23
申请人: Celia Dominguez , Timothy Harvey , Longbin Liu , Aaron Siegmund
发明人: Celia Dominguez , Timothy Harvey , Longbin Liu , Aaron Siegmund
IPC分类号: A61P29/00 , C07D401/04 , C07D401/14 , C07D487/04 , A61K31/53 , A61K31/4965 , A61K31/5377 , C07
CPC分类号: C07D401/14 , C07D401/04 , C07D487/04
摘要: The present invention relates to compounds having the general formula or a pharmaceutically acceptable salt thereof, wherein R1 is a saturated or unsaturated 5-, 6- or 7-membered, ring containing 0, 1, 2 or 3 atoms selected from N, 0 and S, wherein the ring may be fused with a benzo group, and is substituted by 0, 1 or 2 oxo groups, and wherein R1 is additionally substituted; and R2 is a substituted C1-6alkyl. Also included is a method of prophylaxis or treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic β cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.
摘要翻译: 本发明涉及具有通式的化合物或其药学上可接受的盐,其中R 1是饱和或不饱和的含有0,1,2或3个选自N, ,0和S,其中所述环可以与苯并稠合,并且被0,1或2个氧代基取代,并且其中R 1另外被取代; R 2是取代的C 1-6烷基。 还包括预防或治疗炎症,类风湿性关节炎,斑节病,骨质疏松症,多发性骨髓瘤,葡萄膜炎,急性或慢性骨髓性白血病,胰腺β细胞破坏,骨关节炎,类风湿性脊椎炎,痛风性关节炎,炎性肠病,成人呼吸 窘迫综合征(ARDS),牛皮癣,克罗恩病,过敏性鼻炎,溃疡性结肠炎,过敏反应,接触性皮炎,哮喘,肌肉退化,恶病质,赖特综合征,I型糖尿病,II型糖尿病,骨吸收疾病,移植物抗宿主反应, 阿尔茨海默病,中风,心肌梗死,缺血再灌注损伤,动脉粥样硬化,脑外伤,多发性硬化,脑疟疾,败血症,败血性休克,中毒性休克综合征,发热,HIV-1,HIV-2,HIV-3,巨细胞病毒引起的肌痛 (CMV),流感,腺病毒,哺乳动物中的疱疹病毒或带状疱疹感染,包括给予有效量的化合物d 以上所述。
-
公开(公告)号:US20060247263A1
公开(公告)日:2006-11-02
申请号:US11400446
申请日:2006-04-06
申请人: Aaron Siegmund
发明人: Aaron Siegmund
IPC分类号: A61K31/506 , C07D403/02
CPC分类号: C07D401/14 , C07D235/06 , C07D403/12
摘要: The present invention relates to compounds having the general structure: and pharmaceutically acceptable salts and hydrates thereof. Also included is a method of treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic β cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.
摘要翻译: 本发明涉及具有一般结构的化合物及其药学上可接受的盐和水合物。 还包括治疗炎症,类风湿性关节炎,斑节病,骨质疏松症,多发性骨髓瘤,葡萄膜炎,急性或慢性骨髓性白血病,胰腺β细胞破坏,骨关节炎,类风湿性脊椎炎,痛风性关节炎,炎性肠病,成人呼吸窘迫综合征 (ARDS),牛皮癣,克罗恩病,过敏性鼻炎,溃疡性结肠炎,过敏反应,接触性皮炎,哮喘,肌肉变性,恶病质,赖特综合征,I型糖尿病,II型糖尿病,骨吸收疾病,移植物抗宿主反应,阿尔茨海默病 ,中风,心肌梗塞,缺血再灌注损伤,动脉粥样硬化,脑外伤,多发性硬化,脑疟疾,败血症,败血性休克,中毒性休克综合征,发热,HIV-1,HIV-2,HIV-3,巨细胞病毒 ),流感病毒,腺病毒,哺乳动物中的疱疹病毒或带状疱疹感染,包括给予有效量的如上所述的化合物。
-
-
-
-
-
-
-
-